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Analysis of culture medium of human renal adenocarcinoma cells ACHN by RP-HPLC suggested that the ceils specifically secreted human endo- 
thelin-2 (ET-2). cDNAs encoding human ET-2 precursor were cloned from a cDNA library constructed with mRNA derived from the ACHN 
cells, and the nucleotide and deduced amino acid sequences were determined. The ET-2 cDNA was revealed to contain 1.3 kb and encode prepro- 
ET-2 protein consisting of 178 amino acid residues. The ET-like sequence found in the prepro-ET-I and -ET-3 wasconserved in this prepro-ET-2. 
The Northern blot analysis of mRNA suggested that the transcript of ET-2 gene was 1.4 kb. This is the first direct evidence that human ET-2 
gene was expressed specifically intumor cells. 
Human endothelin-2; cDNA cloning; Gene expression; ACHN cell 
1. INTRODUCTION 
In an earlier work a novel vasoconstrictor peptide, 
endothelin, was purified from a culture medium of por- 
cine aortic endothelial cells, and its structure and the 
nucleotide sequences of the cloned cDNA encoding the 
precursor were determined [1]. Also, human cDNA en- 
coding prepro-endothelin has been cloned, and the 
amino acid sequences of human and porcine endothelin 
have been identified [2]. Recently, human endothelin 
has been suggested to have a gene family comprised of
endothelin-1 (ET-1), the first to be recognized, -2 
(ET-2) and -3 (ET-3), respectively [3]. Based on the 
deduced amino acid sequences of the cloned ET-2 and 
ET-3 gene, ET-2 and ET-3 have been chemically s n- 
thesized and the biological activities as the vasoconstric- 
tor of  these ETs have been studied. ET-2 was found to 
have the most potent vasoconstrictive activity among 
these 3 isopeptides [3]. Direct evidence of the gene ex- 
pression of ET-3 has recently been revealed by cDNA 
cloning, Northern blot analysis and the enzyme im- 
munoassay specific for ET-3 [4,5,6]. ET-3 was found to 
be abundant especially in the rat brain [6]. 
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In contrast o ET-3, little is known about the expres- 
sion of  human ET-2 gene. Very recently cloning of the 
cDNA encoding precursor of ET-2 has been reported 
[7]. 
We previously suggested that ET-2 gene expression 
might occur in COS-7 cells (SV-40 transformed African 
green monkey kidney cells). Normal kidney cell lines 
derived from some species have been found to secrete 
immunoreactive endothelins [8]. Our studies on animal 
organs and especially on human cell lines which syn- 
thesize ETs revealed that the human renal adenocar- 
cinoma cell line ACHN specifically secretes immuno- 
reactive ET-2, which was characterized by RP-HPLC 
(to be published). To understand the physiological roles 
of ET-2 and mechanisms of gene expression, we tried to 
clone the cDNA encoding the precursor of ET-2 from a 
cDNA library constructed with mRNA derived from 
the ACHN cells. 
We present here the structure of cDNA encoding the 
precursor of human ET-2 and direct evidence of ET-2 
gene expression specifically in human renal adenocar- 
cinoma cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Dulbecco's minimum essential medium (DMEM) was obtained 
from Gibco, and fetal calf serum was from Biochem. Guanidine 
isothiocyanate was obtained from Fluka. 
Restriction enzymes, T4 ligase, EcoRI linker were obtained from 
New England Biolabs (Beverly, MA, USA) and Nippon Gene (Tokyo, 
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Japan). Exonuclease III and VII were from Takara Shuzo (Kyoto, 
Japan) and Bethesda Research Labs. [oe-32p]dCTP was obtained from 
Amersham Co. 
2.2. Cell culture 
A human kidney tumor cell line (human renal adenocarcinoma), 
ACHN, was obtained from the American Type Culture Collection. 
The cells were cultured in Falcon plastic dishes, 5 cm diameter, with 
DMEM supplemented with 10% fetal calf serum under the humi- 
dified condition of 5% CO2 and 95% air at 37°C. To prepare mes- 
senger RNA (mRNA), ACHN cells were cultured in 150 cm 2 bottles 
(Falcon) for 3 days. 
2.3. Enzyme immunoassay (EIA) 
Endothelin-1, -2and -3 specific enzyme immunoassay s stems were 
described previously [9]. 
2.4. Reverse phase-high performance liquid chromatography 
(RP-HPLC) of the culture medium of ACHN cells 
Serum-free culture of the ACHN cells was conducted after the cells 
became confluent, and for two days the culture medium was 
harvested for partial characterization f the secreted endothelin with 
RP-HPLC (TSK-ODS-80 column, 4.6 × 250 mm, Tosoh, Japan) as 
described before [8]. 
2.5. Northern blot analysis 
Total RNA was extracted from the cultured ACHN cells harvested 
3 days after cell seeding using guanidine-isothiocyanate as d scribed 
[10]. A poly(A) + RNA was prepared with oligo-dT cellulose spun col- 
umn obtained from Pharmacia. A 15/zg portion of poly (A) + RNA 
was treated with formaldehyde and formamide as described [11], and 
subjected to electrophoresis on 1% agarose gel. 
The separated RNA was transferred to nylon membrane (Pall) 
followed by heating at 80°C for 3 h. The filter was hybridized with 
32p-labelled 99mer oligonucleotides corresponding to the 33 amino 
acid residues including mature ET-2 predicted from the nucleotide se- 
quences of human ET-2 gene in hybridization buffer containing 50% 
formamide at 42°C for 20 h. After hybridization, the filter was wash- 
ed with 2 x SSC buffer (saline sodium citrate solution; 1 × SSC = 
sodium chloride, 8.765 g/l, sodium citrate, 4.41 g/I) followed by 
0.2 × SSC containing 0.1% SDS at 65°C. 
2.6 Construction fcDNA library 
A 5/zg of poly(A) + RNA prepared from ACHN cells was used to 
construct a cDNA library with ,~ phage gtl I using a cDNA cloning kit 
(Amersham). 
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Fig. 1. RP-HPLC profiles of the cultured medium of human renal 
adenocarcinoma cells (ACHN). Each fraction was concentrated by
lyophilization and subjected to EIA specific for ET-I (ET-2) and 
ET-3. The arrow shows the position of synthetic endothelin isopep- 
tides eluted on this column. 
3. RESULTS 
3.1. Detection of the immunoreactive endothelin in 
culture medium of A CHN cells 
We had been searching for the cell lines which secrete 
immunoreactive endothelins and found some, e.g. 
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2.7. Cloning and sequence analysis of endothelin-2 cDNA 
The cDNA library containing 1.5 x 104 phage clones was screened 
with 3zP-labelled 150 bp DNA, NcoI-SphI human genomic DNA frag- 
ment containing whole ET-2 sequences previously cloned (unpublish- 
ed results) and 99mer oligonucleotides corresponding to the 33 amino 
acids from His to Val, the l lth amino acid from Cys of N-terminal 
of ET-2 and the next amino acid of Trp of C-terminal, including 
whole ET-2 sequences that were predicted from the human genomic 
ET-2 DNA [3]. Plaque hybridization was conducted at 58°C for 16 h 
and washed with 2xSSC buffer at 56°C. The insert DNAs of 
hybridization positive clones, AHET-26, -27, -31, -35, -52 were 
amplified by polymerase chain reaction (PCR) with Agtl I primers, 
5'GGTGGCGACGACTCCTGGAGCCCG and 5'TTGACACC- 
AGACCAACTGGTAAATG (Takara Shuzo, Kyoto) as described 
[12]. The amplified cDNAs were treated with EcoRI and subcloned 
into the EcoRl sites of plasmid pUC 118. After preparation of single 
stranded DNA with helper phage M13KO7 [13], the nucleotide se- 
quences were determied by the dideoxynucleotide chain termination 
method [14]. 
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Fig. 2. Northern blot of the poly(A) ÷ RNA derived from ACHN cells. 
The molecular size markers are indicated on the left in kilo base. 
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Fig. 3. Restriction enzyme map and sequencing strategy for the 
cDNA insert in the plasmid pHET-2(K). The coding nucleotide s - 
quences for prepro-ET-2 and mature ET-2 are indicated by open and 
closed boxes, respectively. 
COS-7 [8] and Hep G2 [15]. However, these cell lines 
secreted a small amount of a mixture of immunoreac- 
tive ET-1 and ET-2, which were characterized with RP- 
HPLC.  The human renal adenocarcinoma cell line 
ACHN studied here was found to secrete a relatively 
large amount of immunoreactive endothelin into the 
culture medium. The ACHN cells produced immuno- 
reactive ndothelin in parallel with cell growth and the 
contents reached a plateau at 700-800 pg/ml at 7 days 
after cell seeding in a culture medium (data not shown). 
To examine the type of immunoreactive endothelins, 
the cultured medium of the cells was analyzed by RP- 
HPLC.  The elution profiles of the immunoreactive en- 
dothelin are shown in Fig. 1. The position of the eluted 
immunoreactive material was the same position as that 
of synthetic ET-2. 
3.2. Detection of transcript related to endothelin-2 
gene 
To examine the expression levels and the size of the 
transcript of ET-2 gene, a 15/zg portion of poly (A) ÷ 
RNA derived from ACHN cells was analyzed by Nor- 
thern blotting with ET-2 specific 32p-labelled 99mer 
oligonucleotides a  described in Section 2. As shown in 
Fig. 2, a single band was observed near the 1.4 kb size 
marker supporting the ET-2 gene expression in ACHN 
cells. 
3.3. Cloning and sequence analysis of  cDNAs encoding 
the precursor of human endothelin-2 
The amplified, EcoRI digested cDNA inserts of 
AHET-26, -27, -31, -35, and -52 were subcloned into the 
EcoRI site of plasmid pUC 118 and named 
pHET-2(26), -2(27), -2(31), -2(35), and pHET-2(K) 
(Human Endothelin-2 cDNA from Kidney cell), respec- 
I AGGACGCTGGCAACAGGCACTCCCTGCTCCAGTCCAGCCTGCGCGCTCCACCGCCGCT 58 
59 ATG GTC TCC GTG CCT ACC ACC TGG TGC TCC GTT GCG CTA GCC CTG CTC GTG GCC CTG CAT 118 
I Met Val  Ser Val Pro Thr Thr Trp Cys Ser Val  Ala Leu Ala Leu Leu Val  A la  Leu His 20 
I 
119 GAA GGG AAG GGCYCAG GCT GCT GCC ACC CTG GAG CAG CCA GCG TCC TCA TCT CAT GCC CAA 178 
21 Glu Gly Lys Gly Gln Ala  Ala Ala Thr Leu Glu Gln Pro Ala Set Ser Set His A la  Gln 40 
179 GGC ACC CAC CTT CGG CTT CGC CGT TGC TCC TGC AGC TCC TGG CTC GAC AAG GAG TGC GTC 238 
41 Gly Thr  His Leu Arg Leu Arg Arg Cys Ser Cys Ser Ser Trp Leu Asp Lys Glu Cys Val 60 
239 TAC TTC TGC CAC TTG GAC ATC ATC TGG]GTG AAC ACT CCT GAA CAG ACA GCT CCT TAC GGC 298 
61 Tyr  Phe Cys His Leu Asp Ile I le Trp JVa l  Asn Thr Pro Glu Gln Thr A la  Pro Tyr  Gly  80 
i 
299 CTG GGA AAC CCG CCA AGA CGC CGG CGC CGC TCC CTG CCA AGG CGC TGT CAG TGC TCC AGT 358 
81 Leu Gly Asn Pro Pro Arg Arg Arg Arg Arg Ser Leu Pro Arg Arg Cys Gln Cys Ser  Ser 100 
359 GCC AGG GAC CCC GCC TGT GCC ACC TTC TGC CTT CGA AGG CCC TGG ACT GAA GCC GGG GCA 418 
101 Ala Arg Asp Pro Ala  Cys Ala Thr Phe Cys Leu Arg Arg Pro Trp Thr Glu Ala Gly  Ala 120 
419 GTC CCA AGC CGG AAG TCC CCT GCA GAC GTG TTC CAG ACT GGC AAG ACA GGG GCC ACT ACA 478 
121 Val Pro Ser  Arg Lys Ser Pro Ala Asp Val Phe Gln Thr Gly  Lys Thr Gly  A la  Thr  Thr  140 
479 GGA GAG CTT CTC CAA AGG CTG AGG GAC ATT TCC ACA GTC AAG AGC CTC TTT GCC AAG CGA 538 
141 Gly Glu Leu Leu Gln Arg Leu Arg Asp I le Ser Thr Val Lys Ser Leu Phe Ala Lys Arg 160 
539 CAA CAG GAG GCC ATG CGG GAG CCT CGG TCC ACA CAT TCC AGG TGG AGG AAG AGA TAG TGT 598 
161 Gln Gln Glu Ala  Met Arg Glu Pro Arg Ser Thr  His Ser Arg Trp Arg Lys Arg  *** 178 
599 CGTGAGCTGGAGGAACATTGGGAAGGAAGCCCGCGGGGAGAGAGGAGGAGAGAAGTGGCCAGGGCTTGTGGACTCTCTG 677 
678 CCTGCTTCCTGGACCGGGGCCTTGGTCCCAGACAGCTGGACCCATTTGCCAGGATTGGCACAAGCTCCCTGGTGAGGGA 756 
757 GCCTCGTCCAAGGCAGTTCTGTGTCCTCGCACTGCCCAGGGAAGCCCTCGGCCTCCAGACTGCGGAGCAGCCTCCAGTG 835 
836 CTGGCTGCTGGCCCACAGCTCTGCTGGAAGAACTGCATGGGGAGTACATTCATCTGGAGGCTGCGTCCTGAGGAGTGTC 914 
915 CTGTCTGCTGGGCTACAAACCAGGAGCAACCGTGCAGCCACGAACACGCATGCCTCAGCCAGCCCTGGAGACTGGATGG 993 
994 CTCCCCTGAGGCTGGCATCCTGGCTGGCTGTGTCCTCTCCAGCTTTCCCTCCCCAGAGTTCTTGCACCCTCATTCCCTC 1072 
1073 GGGACCCTCCCAGTGAGAAGGGCCTGCTCTGCTTTTCCTGTCTGTATATAACTTATTTGCCCTAAGAACTTTGAGAATC 1151 
1152 CCAATTATTTATTTTAATGTATTTTTTAGACCCTCTATTTACCTGCGAACTTGTGTTTATAATAAATGAGGAAACATCA 1230 
1231 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 1293 
Fig. 4. Nucleotide sequence and predicted amino acid sequence ofthe human prepro-endothelin-2 cDNA. The amino acid and nucleotide s quences 
of mature ET-2 are boxed. Endothelin-like sequence is underlined. The dibasic amino acid pairs are doubly underlined. The probable cleavage site 
of the signal peptide is indicated by an arrow. The polyadenylation signal sequence is indicated by broken underlining. 
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tively. The partial restriction enzyme ap and sequence 
strategy of the longest insert cDNA of pHET-2(K) are 
shown in Fig. 3. 
The sequenced nucleotides of ET-2 cDNA of 
pHET-2(K) was 1218 bp, which encodes the prepro- 
ET-2 protein consisting of 178 amino acid residues. A
putative polyadenylation signal sequence AATAAA 
was present at the 3'-terminus. The cDNAs of 
pHET-2(3 l) and pHET-2(35) were also revealed to have 
a poly(A) tail. So, the total sequenced nucleotides of 
ET-2 cDNA were 1293 bp including poly (A) (64 bp) as 
presented in Fig. 4. Considering the size of ET-2 gene 
transcript, he molecular size of the cloned ET-2 cDNA 
was reasonable. 
Other clones were also examined to determine the 
nucleotide sequences, but were found to be incomplete 
and showed no open reading frame. However, they en- 
code a part of prepro-ET-2 sequence and their nucleo- 
tide sequences were conserved. The clones pHET-2(27), 
pHET-2(31) and pHET-2(35) had deleted 64, 101 and 
284 bp from the 5'terminus of the nucleotide sequence 
of ET-2 cDNA shown in Fig. 4. 
The molecular mass of the prepro-ET-2 was calcu- 
lated to be 19 958 Da. The N-terminal 24 amino acids of 
prepro-ET-2 may be the signal sequence, which can be 
predicted by the method of von Heijne [16]. The amino 
acid sequence of the mature ET-2, Cys49-Trp 69, is box- 
ed in the figure. 
The big form, which was observed in the prepro-ET-1 
and -ET-3 as big-ET-1 (1-38 amino acids) and big-ET-3 
(1-42 amino acids), was also found in this prepro-ET-2. 
Big-ET-2 was found to consist of 37 amino acid residues 
from the amino acid number Cys49-Pro 85 and might be 
cleavable at the dibasic amino acid pairs Arg47-Arg 48 
and Arg86-Arg 87. Thus big-ET-2 was the smallest of 
these 3 big-ETs. The endothelin-like (ET-like) se- 
quence, Cys96-Leu zll with 4 cysteine residues at the 1, 
3, 11, and 15 positions, was also conserved as in the 
prepro-ET-I and-ET-3. 
In the prepro-ET-2, ET-like peptide, in contrast 
to that observed in prepro-ET-1 and -ET-3, may be 
cleaved by peptidase because di-basic amino acid pairs 
of Arg94-Arg 95 and Argl~2-Arg113 are present at the N- 
and C-terminals of this peptide. The biological function 
of this peptide remains to be resolved. 
4. DISCUSSION 
We had shown the structures of the human prepro- 
ET-1 and -ET-3 before [2,5]. In addition to these struc- 
tures, the human prepro-ET-2 has been revealed now. 
Here the structural relationships among prepro-ETs are 
shown in Fig. 5. The amino acid sequences of the 
prepro-ET-I predicted from the nucleotide sequences of
cDNA cloned from placenta [2], lung (unpublished 
data), and umbilical vein endothelial cells [17] were 
identical and consisted of 212 amino acid residues. 
However, there are some differences inthe prepro-ET-2 
and -ET-3. For example, the prepro-ET-3 derived from 
placenta consisted of 224 amino acid residues [5], but 
that from the hypothalamus was 238 amino acid 
residues [4]. In addition to these amino acid differen- 
ces, 220 bp insertion or deletion was found in these two 
ET-3 cDNAs. However, the expression of the cloned 
ET-3 cDNA from human placenta in COS-7 and 
chinese hamster ovary cells confirmed that the structure 
of the ET-3 cDNA was reasonable for transcription and 
translation [5]. 
The prepro-ET-2 from ACHN cells consisted of 178 
amino acid residues, however that from the small in- 
testine had 145 amino acid residues [7]. Some hint as to 
the reason for these discrepancies might be obtained by 
examining the structures of the intron and exon in each 
genomic DNA. The most reasonable explanation may 
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Fig. 5. Structures of prepro-endothelins predicted from their corresponding cDNAs. N-terminal signal sequences are indicated by heavy cross- 
hatching, the mature endothelins by double crosses and the big-ETs by light crosshatching. Endothelin-like sequences are dotted. 
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be that an alternative splicing occurred. In the case of  
the ET-2 gene, the ET-2 transcript expressed in small in- 
testine might have no 4th exon present on genomic 
DNA [7]. 
The biological activity of  endothelin, which was first 
found to be vasoconstrictor, has been studied extensive- 
ly in many systems including the vascular one [18]. One 
of  the reported endothelin activities is the stimulation 
of  c-fos and c-myc gene expression by ET- I  [19]. The 
tissue distribution of  endothelin isopeptides, ET- I ,  -2 
and -3, which may contribute to further understanding 
of  the biological activities has been studied in the rat 
and the possibility of  ET-3 functioning as a brain-gut 
peptide has been presented [6]. Thus, endothelin 
isopeptides are revealed to be produced in other non- 
endothelial cells. 
It has been reported that tumor cell lines, including 
COS-7 cells, HepG2 (hepatocellular carcinoma) and 
WiDr (colon carcinoma) produce endothelin isopep- 
tides, ET-1 and ET-2 [8,15]. In addition to these cell 
lines, we have shown that the human renal adenocar- 
c inoma cell line ACHN are typical cells which secrete a 
large amount of  only ET-2 (to be published). In confir- 
ming the ET-2 gene expression by cloning the cDNA en- 
coding prepro-ET-2, we have presented here a new view 
of  endothelins and tumors which should lead to better 
understanding of relationships between endothelins and 
oncogene xpression. 
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